Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-475 + Atorvastatin in Primary Hypercholesterolemia
NCT00864643Phase 2Completed
- Sponsor
- Takeda
- Start
- Sep 2004
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lapaquistat in hypercholesterolemia, sponsored by Takeda. Started Sep 2004; status: completed.
02
Drugs
lapaquistat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00864643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00864643.